174 related articles for article (PubMed ID: 22623369)
21. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.
Cantiani L; Manara MC; Zucchini C; De Sanctis P; Zuntini M; Valvassori L; Serra M; Olivero M; Di Renzo MF; Colombo MP; Picci P; Scotlandi K
Cancer Res; 2007 Aug; 67(16):7675-85. PubMed ID: 17699771
[TBL] [Abstract][Full Text] [Related]
22. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
Brun J; Dieudonné FX; Marty C; Müller J; Schüle R; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
PLoS One; 2013; 8(1):e55034. PubMed ID: 23383046
[TBL] [Abstract][Full Text] [Related]
23. E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells.
Xu L; Zhang Y; Qu X; Che X; Guo T; Cai Y; Li A; Li D; Li C; Wen T; Fan Y; Hou K; Ma Y; Hu X; Liu Y
Neoplasia; 2017 Apr; 19(4):374-382. PubMed ID: 28334634
[TBL] [Abstract][Full Text] [Related]
24. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
Paolino M; Choidas A; Wallner S; Pranjic B; Uribesalgo I; Loeser S; Jamieson AM; Langdon WY; Ikeda F; Fededa JP; Cronin SJ; Nitsch R; Schultz-Fademrecht C; Eickhoff J; Menninger S; Unger A; Torka R; Gruber T; Hinterleitner R; Baier G; Wolf D; Ullrich A; Klebl BM; Penninger JM
Nature; 2014 Mar; 507(7493):508-12. PubMed ID: 24553136
[TBL] [Abstract][Full Text] [Related]
25. E3 ubiquitin ligase Cbl-b suppresses human ORMDL3 expression through STAT6 mediation.
Yang WX; Jin R; Jiang CM; Wang XH; Shu J; Li L; Zhu LH; Zhuang LL; Gao C; Zhou GP
FEBS Lett; 2015 Jul; 589(15):1975-80. PubMed ID: 26112603
[TBL] [Abstract][Full Text] [Related]
26. The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells.
Truitt L; Freywald T; DeCoteau J; Sharfe N; Freywald A
Cancer Res; 2010 Feb; 70(3):1141-53. PubMed ID: 20086179
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of ubiquitin ligase Cbl induced by twist haploinsufficiency in Saethre-Chotzen syndrome results in increased PI3K/Akt signaling and osteoblast proliferation.
Guenou H; Kaabeche K; Dufour C; Miraoui H; Marie PJ
Am J Pathol; 2006 Oct; 169(4):1303-11. PubMed ID: 17003487
[TBL] [Abstract][Full Text] [Related]
28. Casitas B-cell lymphoma (Cbl) proteins protect mammary epithelial cells from proteotoxicity of active c-Src accumulation.
Mukhopadhyay C; Triplett A; Bargar T; Heckman C; Wagner KU; Naramura M
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8228-E8237. PubMed ID: 27930322
[TBL] [Abstract][Full Text] [Related]
29. The Cbl family proteins: ring leaders in regulation of cell signaling.
Swaminathan G; Tsygankov AY
J Cell Physiol; 2006 Oct; 209(1):21-43. PubMed ID: 16741904
[TBL] [Abstract][Full Text] [Related]
30. Loss of function Cbl-c mutations in solid tumors.
Daniels SR; Liyasova M; Kales SC; Nau MM; Ryan PE; Green JE; Lipkowitz S
PLoS One; 2019; 14(7):e0219143. PubMed ID: 31260484
[TBL] [Abstract][Full Text] [Related]
31. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
[TBL] [Abstract][Full Text] [Related]
32. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors.
Makishima H; Sugimoto Y; Szpurka H; Clemente MJ; Ng KP; Muramatsu H; O'Keefe C; Saunthararajah Y; Maciejewski JP
Leukemia; 2012 Jul; 26(7):1547-54. PubMed ID: 22246246
[TBL] [Abstract][Full Text] [Related]
33. c-Cbl ubiquitin ligase regulates focal adhesion protein turnover and myofibril degeneration induced by neutrophil protease cathepsin G.
Rafiq K; Guo J; Vlasenko L; Guo X; Kolpakov MA; Sanjay A; Houser SR; Sabri A
J Biol Chem; 2012 Feb; 287(8):5327-39. PubMed ID: 22203672
[TBL] [Abstract][Full Text] [Related]
34. A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis.
Singh AJ; Meyer RD; Navruzbekov G; Shelke R; Duan L; Band H; Leeman SE; Rahimi N
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5413-8. PubMed ID: 17372230
[TBL] [Abstract][Full Text] [Related]
35. The E3 ubiquitin ligase Cbl-b inhibits tumor growth in multidrug-resistant gastric and breast cancer cells.
CHe X; Zhang Y; Qu X; Guo T; Ma Y; Li C; Fan Y; Hou K; Cai Y; Yu R; Zhou H; He X; Wu H; Liu Y; Xu L
Neoplasma; 2017; 64(6):887-892. PubMed ID: 28895413
[TBL] [Abstract][Full Text] [Related]
36. c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis.
Lyle CL; Belghasem M; Chitalia VC
Cells; 2019 May; 8(5):. PubMed ID: 31126146
[TBL] [Abstract][Full Text] [Related]
37. c-Cbl regulates glioma invasion through matrix metalloproteinase 2.
Lee H; Tsygankov AY
J Cell Biochem; 2010 Dec; 111(5):1169-78. PubMed ID: 20717917
[TBL] [Abstract][Full Text] [Related]
38. YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK.
Chang LC; Lin HY; Tsai MT; Chou RH; Lee FY; Teng CM; Hsieh MT; Hung HY; Huang LJ; Yu YL; Kuo SC
Br J Pharmacol; 2014 Sep; 171(17):4010-25. PubMed ID: 24697523
[TBL] [Abstract][Full Text] [Related]
39. PTK6 promotes degradation of c-Cbl through PTK6-mediated phosphorylation.
Kang SA; Lee ST
Biochem Biophys Res Commun; 2013 Feb; 431(4):734-9. PubMed ID: 23352614
[TBL] [Abstract][Full Text] [Related]
40. Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function.
Li Z; Dong T; Pröschel C; Noble M
PLoS Biol; 2007 Feb; 5(2):e35. PubMed ID: 17298174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
